Výsledky vyhledávání - "Laurent Licini"

Safety and immunogenicity of an investigational 4-componentStaphylococcus aureusvaccine with or without AS03Badjuvant: Results of a randomized phase I trial

Autor: Edwige Haelterman, Philippe Moris, Laurent Licini, Jack Levy, Dominique Boutriau, Pascale Van Belle, Silvia Damaso, Pascal Lestrate

Publikováno v: Human Vaccines & Immunotherapeutics

We assessed the safety, reactogenicity and immunogenicity of a staphylococcal vaccine combining capsular polysaccharides types 5 and 8 (CPS5/8), conjugated to tetanus toxoid (TT), with mutated detoxified α-toxin (AT) and clumping factor A (ClfA). In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2358e7224117d1e0ff5ac26beeaf9382
https://doi.org/10.1080/21645515.2015.1011021

Zobrazit plný text záznamu

Randomized trial of the immunogenicity and safety of the hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18 AS04-adjuvanted cervical cancer vaccine

Autor: Fien De Boever, Dominique Descamps, Cathy Maes, Edwige Haelterman, Laurent Licini, Kurt Dobbelaere, Marie Pierre David, Geert Leroux-Roels, Jack Levy

Publikováno v: Clinical and Vaccine Immunology (Print), 18 (9
CLINICAL AND VACCINE IMMUNOLOGY

The human papillomavirus type 16/18 (HPV-16/18) AS04-adjuvanted cervical cancer vaccine is licensed for females aged 10 years and above and is therefore likely to be coadministered with other licensed vaccines, such as hepatitis B. In this randomized

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::612fcafb800ac24bd36464f2370a4aa4
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/188607

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání